Description and Brand Names
US Brand Name
Trametinib is used alone or in combination with dabrafenib to treat melanoma (skin cancer) that has spread or cannot be removed by surgery, non-small cell lung cancer (NSCLC) that has spread, and anaplastic thyroid cancer (ATC) that has spread and has no satisfactory treatment options. It is also used together with dabrafenib to help prevent melanoma from coming back after surgery. It is only used if the melanoma cells have the BRAF V600E or V600K mutations and if the NSCLC cells and ATC cells have the BRAF V600E mutation. Your doctor will use a special test to look for these mutations. Trametinib belongs to the group of medicines, called antineoplastics (cancer medicines).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: